ID

36435

Descripción

Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets; ODM derived from: https://clinicaltrials.gov/show/NCT01510522 Brief Summary: This is an open-label, multicenter, two-arm, parallel, randomized phase 4 study to compare the compliance in diabetes type 2 patients treated with Glucophage sachets versus patients treated with Glucophage tablets.

Link

https://clinicaltrials.gov/show/NCT01510522

Palabras clave

Versiones (2)
  1. 16/1/19 16/1/19 -
  2. 14/5/19 14/5/19 -
Titular de derechos de autor

Merck KGaA, Darmstadt, Germany

Subido en

14 de mayo de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Adherence to Glucophage Sachets vs Tablets in Type 2 Diabetes NCT01510522

Inglés

Eligibility Criteria

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
Is type 2 diabetes diagnosed?
Descripción

Diabetes mellitus type 2 should be diagnosed: baseline glycemia > 7,0 mmol/l (126 mg/dl) or overload glycemia > 11,0 mmol/l (198 mg/dl) as criteria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
Is the patient being treated with metformin tablets?
Descripción

Metformin treatment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0039225
Does the patient have at least 2 comorbidities?
Descripción

Patients shoudl have at least 2 treated co-morbidities

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
Does the patient have an established dose of metformin > 1.700 mg/day?
Descripción

Patients should have an established dose of metformin > 1.700 mg/day

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C2348070
UMLS CUI [1,3]
C0443211
Is the patient over 18 years old?
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
Is informed consent given?
Descripción

Informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
Is the patient able to take medication orally?
Descripción

Patients not able to take medication orally should be excluded

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2712086
UMLS CUI [1,2]
C0175795
Are there exclusions given according to summary of product characteristics (smpc)?
Descripción

Are there exclusions given according to summary of product characteristics (smpc)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0332290
UMLS CUI [1,3]
C1709515
Does the patient participate in another clinical trial 30 days prior to randomization?
Descripción

Different clinical trial

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0332185
Are the any other illness or medical or psychiatric conditions, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results?
Descripción

Other confounding illnesses

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0205318
UMLS CUI [1,4]
C0521102
UMLS CUI [1,5]
C2348568
UMLS CUI [2,1]
C0221423
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0205318
UMLS CUI [2,4]
C0521102
UMLS CUI [2,5]
C0683954
UMLS CUI [3,1]
C0205476
UMLS CUI [3,2]
C0348080
UMLS CUI [3,3]
C0205082
UMLS CUI [3,4]
C0205318
UMLS CUI [3,5]
C0521102
UMLS CUI [3,6]
C2348568
UMLS CUI [4,1]
C0205476
UMLS CUI [4,2]
C0348080
UMLS CUI [4,3]
C0205082
UMLS CUI [4,4]
C0205318
UMLS CUI [4,5]
C0521102
UMLS CUI [4,6]
C0683954
UMLS CUI [5,1]
C0004936
UMLS CUI [5,2]
C0205082
UMLS CUI [5,3]
C0205318
UMLS CUI [5,4]
C0521102
UMLS CUI [5,5]
C2348568
UMLS CUI [6,1]
C0004936
UMLS CUI [6,2]
C0205082
UMLS CUI [6,3]
C0205318
UMLS CUI [6,4]
C0521102
UMLS CUI [6,5]
C0683954
Volver a la parte superior de la página

Similar models

Eligibility Criteria

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Diagnosed type 2 diabetes
Item
Is type 2 diabetes diagnosed?
boolean
C0011860 (UMLS CUI [1])
Metformin treatment
Item
Is the patient being treated with metformin tablets?
boolean
C0025598 (UMLS CUI [1,1])
C0039225 (UMLS CUI [1,2])
Comorbidities
Item
Does the patient have at least 2 comorbidities?
boolean
C0009488 (UMLS CUI [1])
Daily Metformin dose
Item
Does the patient have an established dose of metformin > 1.700 mg/day?
boolean
C0025598 (UMLS CUI [1,1])
C2348070 (UMLS CUI [1,2])
C0443211 (UMLS CUI [1,3])
Age
Item
Is the patient over 18 years old?
boolean
C0001779 (UMLS CUI [1])
Informed consent
Item
Is informed consent given?
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Ability to take medication p.o.
Item
Is the patient able to take medication orally?
boolean
C2712086 (UMLS CUI [1,1])
C0175795 (UMLS CUI [1,2])
Exclusion by SMPC
Item
Are there exclusions given according to summary of product characteristics (smpc)?
boolean
C0680251 (UMLS CUI [1,1])
C0332290 (UMLS CUI [1,2])
C1709515 (UMLS CUI [1,3])
Different clinical trial
Item
Does the patient participate in another clinical trial 30 days prior to randomization?
boolean
C2348568 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Other confounding illnesses
Item
Are the any other illness or medical or psychiatric conditions, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results?
boolean
C0221423 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C0521102 (UMLS CUI [1,4])
C2348568 (UMLS CUI [1,5])
C0221423 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0205318 (UMLS CUI [2,3])
C0521102 (UMLS CUI [2,4])
C0683954 (UMLS CUI [2,5])
C0205476 (UMLS CUI [3,1])
C0348080 (UMLS CUI [3,2])
C0205082 (UMLS CUI [3,3])
C0205318 (UMLS CUI [3,4])
C0521102 (UMLS CUI [3,5])
C2348568 (UMLS CUI [3,6])
C0205476 (UMLS CUI [4,1])
C0348080 (UMLS CUI [4,2])
C0205082 (UMLS CUI [4,3])
C0205318 (UMLS CUI [4,4])
C0521102 (UMLS CUI [4,5])
C0683954 (UMLS CUI [4,6])
C0004936 (UMLS CUI [5,1])
C0205082 (UMLS CUI [5,2])
C0205318 (UMLS CUI [5,3])
C0521102 (UMLS CUI [5,4])
C2348568 (UMLS CUI [5,5])
C0004936 (UMLS CUI [6,1])
C0205082 (UMLS CUI [6,2])
C0205318 (UMLS CUI [6,3])
C0521102 (UMLS CUI [6,4])
C0683954 (UMLS CUI [6,5])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial